HEPATITIS D, CHRONIC
Clinical trials for HEPATITIS D, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS D, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS D, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to silence hepatitis d virus
Disease control OngoingThis study tests two experimental drugs, VIR-2218 and VIR-3434, in 95 adults with chronic hepatitis D. The goal is to see if the drugs can lower the virus to undetectable levels and improve liver enzyme levels. Participants receive the drugs and are monitored for safety and effec…
Matched conditions: HEPATITIS D, CHRONIC
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Can a simple blood test tell when hepatitis delta patients can stop medication?
Knowledge-focused OngoingThis study involves 20 adults with chronic hepatitis delta who have been on bulevirtide treatment for at least 48 weeks. Researchers want to find biological markers (biomarkers) that can predict whether the virus will stay under control after stopping the drug. Participants stop …
Matched conditions: HEPATITIS D, CHRONIC
Phase: NA • Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated May 20, 2026 12:08 UTC